Moreover, other studies demonstrated that there is no association between CTLA4 expression in tumor cells and any of the clinicopathological parameters either in breast carcinoma or esophageal squamous cell carcinoma (Lan et al., 2018; Zhang et al., 2019). This evidence concerns the gene CTLA4 and breast carcinoma.